| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5702177 | Practical Radiation Oncology | 2017 | 22 Pages |
Abstract
SABR was well tolerated and resulted in good 1-year local control; PFS was promising for patients with solitary metastases. Low-grade toxicity was common, but can be minimized with strict dosimetric constraints.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
William W. MD, Quynh-Nhu MD, Reza MD, James W. MD, Daniel R. MD, Peter PhD, Ritsuko MD, Zhongxing MD, Joe Y. MD, PhD,